Get insights about how different acts and
regulations impact the global nanopharmaceuticaldrugs market both directly and indirectly. Factors including pricing,
biosafety, regulatory, and intellectual property that are responsible for
influencing the market are governed by these acts and regulations. A market
intelligence report published by BIS Research on global nanopharmaceutical
market also highlights aspects that are responsible for driving the market
including rise in prevalence of chronic diseases for example - cancer, genetic
disorders, cardiovascular diseases, increasing economic burden of healthcare
expenditure, and the rise of geriatric population, among others.
Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...

Comments
Post a Comment